Citadel Advisors’s Tenon Medical Inc Warrant TNONW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$582 Buy
72,721
+1,188
+2% +$13 ﹤0.01% 12845
2025
Q4
$758 Sell
71,533
-797
-1% -$13 ﹤0.01% 12493
2025
Q3
$723 Sell
72,330
-12,574
-15% -$245 ﹤0.01% 12606
2025
Q2
$1.37K Sell
84,904
-63,679
-43% -$1.3K ﹤0.01% 12259
2025
Q1
$3.05K Buy
148,583
+61,466
+71% +$1.26K ﹤0.01% 13989
2024
Q4
$1.02K Sell
87,117
-2,649
-3% -$56 ﹤0.01% 14237
2024
Q3
$2.74K Buy
89,766
+23,748
+36% +$1.09K ﹤0.01% 13721
2024
Q2
$3.29K Sell
66,018
-1,766
-3% -$90 ﹤0.01% 13608
2024
Q1
$3.99K Buy
67,784
+28,515
+73% +$1.33K ﹤0.01% 13853
2023
Q4
$3.14K Buy
39,269
+29,152
+288% +$1.36K ﹤0.01% 13627
2023
Q3
$413 Buy
+10,117
New +$743 ﹤0.01% 14063

Other funds holding TNONW

Citadel Advisors's TNONW Position: Q1 2026 in Review

Citadel Advisors increased its Tenon Medical Inc Warrant (TNONW) stake by 1.7% in Q1 2026, buying an estimated $13 and bringing the position to 72,721 shares worth $582. The position accounts for ﹤0.01% of the portfolio, ranked #12845.

Citadel Advisors first reported a position in TNONW in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.99K in Q1 2024. 11 funds tracked by Wall St. Rank hold TNONW as of Q1 2026.

  • Citadel Advisors held 72,721 shares of Tenon Medical Inc Warrant worth $582 as of Q1 2026.
  • Citadel Advisors bought 1,188 Tenon Medical Inc Warrant shares in Q1 2026, an estimated $13.
  • Tenon Medical Inc Warrant made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12845 holding.
  • Citadel Advisors first reported a position in Tenon Medical Inc Warrant in Q3 2023 and has held it in 11 quarters since.
  • Citadel Advisors's Tenon Medical Inc Warrant position peaked at $3.99K in Q1 2024.
  • 11 funds tracked by Wall St. Rank held Tenon Medical Inc Warrant as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.